Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Hold
4,670
0.8% 23
2025
Q4
$1.53M Hold
4,670
0.7% 21
2025
Q3
$1.32M Hold
4,670
0.62% 24
2025
Q2
$1.3M Hold
4,670
0.65% 22
2025
Q1
$1.45M Buy
4,670
+750
+19% +$221K 0.85% 17
2024
Q4
$1.02M Hold
3,920
0.57% 26
2024
Q3
$1.26M Hold
3,920
0.71% 20
2024
Q2
$1.22M Hold
3,920
0.72% 20
2024
Q1
$1.11M Hold
3,920
0.67% 27
2023
Q4
$1.13M Hold
3,920
0.76% 23
2023
Q3
$1.05M Hold
3,920
0.8% 18
2023
Q2
$870K Buy
+3,920
New +$910K 0.61% 26
2023
Q1
Sell
-3,210
Closed -$843K 122
2022
Q4
$843K Buy
+3,210
New +$860K 0.76% 21
2022
Q3
Sell
-920
Closed -$224K 47
2022
Q2
$224K Buy
+920
New +$225K 0.14% 46

Other funds holding AMGN

Alpha Family Trust's AMGN Position: Q1 2026 in Review

Alpha Family Trust held its Amgen (AMGN) position steady in Q1 2026 at 4,670 shares worth $1.64M. The position accounts for 0.8% of the portfolio, ranked #23.

Alpha Family Trust first reported a position in AMGN in Q2 2022 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alpha Family Trust held 4,670 shares of Amgen worth $1.64M as of Q1 2026.
  • Alpha Family Trust left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.8% of Alpha Family Trust's portfolio in Q1 2026, its #23 holding.
  • Alpha Family Trust first reported a position in Amgen in Q2 2022 and has held it in 14 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.